From Bit to Bedside: A Practical Framework for Artificial Intelligence Product Development in Healthcare

被引:53
作者
Higgins, David [1 ]
Madai, Vince I. [2 ]
机构
[1] Berlin Inst Hlth, Anna Louisa Karchstr 2, D-10178 Berlin, Germany
[2] Charite Univ Med Berlin, CLAIM, Augustenburger Pl 1, D-13353 Berlin, Germany
关键词
artificial intelligence; digital health; healthcare; innovation frameworks; medicine;
D O I
10.1002/aisy.202000052
中图分类号
TP [自动化技术、计算机技术];
学科分类号
0812 ;
摘要
Artificial intelligence (AI) in healthcare holds great potential to expand access to high-quality medical care, while reducing systemic costs. Despite hitting headlines regularly and many publications of proofs-of-concept, certified products are failing to break through to the clinic. AI in healthcare is a multiparty process with deep knowledge required in multiple individual domains. A lack of understanding of the specific challenges in the domain is the major contributor to the failure to deliver on the big promises. Herein, a "decision perspective" framework for the development of AI-driven biomedical products from conception to market launch is presented. The framework highlights the risks, objectives, and key results which are typically required to navigate a three-phase process to market-launch of a validated medical AI product. Clinical validation, regulatory affairs, data strategy, and algorithmic development are addressed. The development process proposed for AI in healthcare software strongly diverges from modern consumer software development processes. Key time points to guide founders, investors, and key stakeholders throughout the process are highlighted. This framework should be seen as a template for innovation frameworks, which can be used to coordinate team communications and responsibilities toward a viable product development roadmap, thus unlocking the potential of AI in medicine.
引用
收藏
页数:14
相关论文
共 53 条
[11]   Advancing a Framework for Regulatory Use of Real-World Evidence: When Real Is Reliable [J].
Dreyer, Nancy A. .
THERAPEUTIC INNOVATION & REGULATORY SCIENCE, 2018, 52 (03) :362-368
[12]  
Englich B., 2016, PERS SOC PSYCHOL B, V2, P188
[13]   A guide to deep learning in healthcare [J].
Esteva, Andre ;
Robicquet, Alexandre ;
Ramsundar, Bharath ;
Kuleshov, Volodymyr ;
DePristo, Mark ;
Chou, Katherine ;
Cui, Claire ;
Corrado, Greg ;
Thrun, Sebastian ;
Dean, Jeff .
NATURE MEDICINE, 2019, 25 (01) :24-29
[14]  
F.D.A, PREC
[15]   When and How Can Real World Data Analyses Substitute for Randomized Controlled Trials? [J].
Franklin, Jessica M. ;
Schneeweiss, Sebastian .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 2017, 102 (06) :924-933
[16]   Where Have All the IPOs Gone? [J].
Gao, Xiaohui ;
Ritter, Jay R. ;
Zhu, Zhongyan .
JOURNAL OF FINANCIAL AND QUANTITATIVE ANALYSIS, 2013, 48 (06) :1663-1692
[17]   Beyond validation: getting health apps into clinical practice [J].
Gordon, William J. ;
Landman, Adam ;
Zhang, Haipeng ;
Bates, David W. .
NPJ DIGITAL MEDICINE, 2020, 3 (01)
[18]   The Fourth Industrial Revolution - Industry 4.0 and IoT [J].
Griffiths, Francis ;
Ooi, Melanie .
IEEE INSTRUMENTATION & MEASUREMENT MAGAZINE, 2018, 21 (06) :29-+
[19]   Explainable AI under contract and tort law: legal incentives and technical challenges [J].
Hacker, Philipp ;
Krestel, Ralf ;
Grundmann, Stefan ;
Naumann, Felix .
ARTIFICIAL INTELLIGENCE AND LAW, 2020, 28 (04) :415-439
[20]   Artificial intelligence in radiology [J].
Hosny, Ahmed ;
Parmar, Chintan ;
Quackenbush, John ;
Schwartz, Lawrence H. ;
Aerts, Hugo J. W. L. .
NATURE REVIEWS CANCER, 2018, 18 (08) :500-510